When will COVID-19 vaccines be available for children?

The FINANCIAL -- Anyone 16 and older is now approved to be vaccinated for COVID-19, but researchers hope to open up vaccinations for those under 16 soon. Clinical trials for the Pfizer vaccine with children ages 12–15 have shown promising results, Mayo…

3 mins read

Virtual shared medical appointments offer break-through

The FINANCIAL -- Virtual health appointments have become widespread during the Covid pandemic, and combining this approach with shared medical appointments could enable health services to break through growing backlogs and “leapfrog into a reality of health for all”, according to the…

5 mins read

Study claims that glasses can lower your risk of COVID-19

The FINANCIAL — A recent study states that wearing glasses can lower the risk of coronavirus. Researchers from Suizhou Zengdu Hospital in Suizhou, China, claim that the use of eye protection, such as glasses, might offer some degree of protection from COVID-19.…

6 mins read

Silknet became the main communication source during pandemic

Silknet – the country’s largest fixed network provider offering households and businesses the full range of telecommunication services, such as mobile services, fixed broadband, Pay TV and fixed telephony. Silknet is rated B1/Stable by Moody’s and B+/Stable by Fitch Ratings. In 2019…

9 mins read

RMG continues its projects and donates GEL 1.5 million amid pandemic

Since the Covid-19 pandemic struck, companieshave been forced to meet significant challenges never seen previously. From slick financial management to monitoring employee interactions, this has arguably become the test of the decade for companies. Georgia’s RMG (Rich Metal Group) have been among…

9 mins read

Synairgen shares rise over 450% as COVID-19 drug has huge potential

The FINANCIAL — Synairgen plc, the respiratory drug discovery and development company which originated from research at the University of Southampton, is pleased to announce positive results from its clinical trial of SNG001, its wholly-owned inhaled formulation of interferon beta, in hospitalised COVID-19…

6 mins read